Washington Trust Advisors’s Greenwich LifeSciences GLSI Stock Holding History

Washington Trust Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.69K	Hold	200	–	–	﹤0.01%	576
2026 Q1	$4.8K	Hold	200	–	–	﹤0.01%	533
2025 Q4	$4.2K	Hold	200	–	–	﹤0.01%	556
2025 Q3	$1.99K	Hold	200	–	–	﹤0.01%	660
2025 Q2	$1.81K	Hold	200	–	–	﹤0.01%	615
2025 Q1	$1.91K	Hold	200	–	–	﹤0.01%	614
2024 Q4	$2.25K	Hold	200	–	–	﹤0.01%	617
2024 Q3	$2.87K	Hold	200	–	–	﹤0.01%	619
2024 Q2	$3.45K	Hold	200	–	–	﹤0.01%	601
2024 Q1	$3.99K	Hold	200	–	–	﹤0.01%	596
2023 Q4	$2.1K	Buy	+200	New	+$2K	﹤0.01%	642

Other funds holding GLSI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Washington Trust Advisors's GLSI Position: Q2 2026 in Review

Washington Trust Advisors held its Greenwich LifeSciences (GLSI) position steady in Q2 2026 at 200 shares worth $4.69K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Washington Trust Advisors first reported a position in GLSI in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.8K in Q1 2026. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

Washington Trust Advisors held 200 shares of Greenwich LifeSciences worth $4.69K as of Q2 2026.
Washington Trust Advisors left its Greenwich LifeSciences share count unchanged in Q2 2026.
Greenwich LifeSciences made up ﹤0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #576 holding.
Washington Trust Advisors first reported a position in Greenwich LifeSciences in Q4 2023 and has held it in 11 quarters since.
Washington Trust Advisors's Greenwich LifeSciences position peaked at $4.8K in Q1 2026.
57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.